These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1820909)

  • 21. Determination of carnitine and acylcarnitines in plasma by high-performance liquid chromatography/electrospray ionization ion trap tandem mass spectrometry.
    Vernez L; Wenk M; Krähenbühl S
    Rapid Commun Mass Spectrom; 2004; 18(11):1233-8. PubMed ID: 15164354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
    Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
    Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enantioselective plasma protein binding of bimoclomol.
    Visy J; Fitos I; Mády G; Urge L; Krajcsi P; Simonyi M
    Chirality; 2002 Aug; 14(8):638-42. PubMed ID: 12125033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carnitine: transport and physiological functions in the brain.
    Nałecz KA; Miecz D; Berezowski V; Cecchelli R
    Mol Aspects Med; 2004; 25(5-6):551-67. PubMed ID: 15363641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effects of propionyl-L-carnitine on plasma extravasation induced by irritants in rodents.
    Amico-Roxas M; Caruso A; Cutuli VM; de Bernardis E; Leonardi G
    Drugs Exp Clin Res; 1993; 19(5):213-7. PubMed ID: 8174493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epimerization of moxalactam by albumin and simulation of in vivo epimerization by a physiologically based pharmacokinetic model.
    Yoshikawa T; Oguma T; Ichihashi T; Kinoshita H; Hirano K; Yamada H
    Chirality; 1999; 11(4):309-15. PubMed ID: 10224658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers.
    Marzo A; Arrigoni Martelli E; Urso R; Rocchetti M; Rizza V; Kelly JG
    Eur J Clin Pharmacol; 1989; 37(1):59-63. PubMed ID: 2591464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sources of error in determinations of carnitine and acylcarnitine in plasma.
    Fishlock RC; Bieber LL; Snoswell AM
    Clin Chem; 1984 Feb; 30(2):316-8. PubMed ID: 6692545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of pharmacokinetics of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine after single oral administration of L-carnitine in healthy volunteers.
    Cao Y; Wang YX; Liu CJ; Wang LX; Han ZW; Wang CB
    Clin Invest Med; 2009 Feb; 32(1):E13-9. PubMed ID: 19178874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. L-Carnitine moiety assay: an up-to-date reappraisal covering the commonest methods for various applications.
    Marzo A; Curti S
    J Chromatogr B Biomed Sci Appl; 1997 Nov; 702(1-2):1-20. PubMed ID: 9449551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Free and total carnitine concentrations in pig plasma after oral ingestion of various L-carnitine compounds.
    Eder K; Felgner J; Becker K; Kluge H
    Int J Vitam Nutr Res; 2005 Jan; 75(1):3-9. PubMed ID: 15830915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of oral acetyl-L-carnitine in renal impairment.
    Kelly JG; Hunt S; Doyle GD; Laher MS; Carmody M; Marzo A; Arrigoni Martelli E
    Eur J Clin Pharmacol; 1990; 38(3):309-12. PubMed ID: 2340852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of L-carnitine.
    Evans AM; Fornasini G
    Clin Pharmacokinet; 2003; 42(11):941-67. PubMed ID: 12908852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of IV and oral acetyl-L-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer type.
    Parnetti L; Gaiti A; Mecocci P; Cadini D; Senin U
    Eur J Clin Pharmacol; 1992; 42(1):89-93. PubMed ID: 1541322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromatographic and non-chromatographic assay of L-carnitine family components.
    Marzo A; Cardace G; Monti N; Muck S; Arrigoni Martelli E
    J Chromatogr; 1990 May; 527(2):247-58. PubMed ID: 2201692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Equilibrium gel filtration to measure plasma protein binding of very highly bound drugs.
    Weiss HM; Gatlik E
    J Pharm Sci; 2014 Feb; 103(2):752-9. PubMed ID: 24375113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The binding of 99mTc(Sn)-MDP complexes to human serum albumin and other blood proteins determined with gel chromatography and ultrafiltration.
    Huigen YM; Tji TG; Gelsema WJ; de Ligny CL
    Int J Rad Appl Instrum A; 1989; 40(7):629-35. PubMed ID: 2551860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholinesterase-catalyzed resolution of D,L-carnitine.
    Dropsy EP; Klibanov AM
    Biotechnol Bioeng; 1984 Aug; 26(8):911-5. PubMed ID: 18553477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative and qualitative aspects of the plasma protein binding of carbenoxolone, an ulcer-healing drug.
    Parke DV; Lindup WE
    Ann N Y Acad Sci; 1973 Nov; 226():200-13. PubMed ID: 4203419
    [No Abstract]   [Full Text] [Related]  

  • 40. Application of high-performance liquid chromatography to the analysis of propionyl-L-carnitine by a stereospecific enzyme assay.
    Marzo A; Monti N; Ripamonti M; Arrigoni Martelli E
    J Chromatogr; 1988 Dec; 459():313-7. PubMed ID: 3243906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.